Archived Medical News Stories

<< Back to Main Archives Index

RSSArchived Pharmaceutical News Stories - March 2009

Date Title Comments Rating
2009-03-31 House subcommittee to conduct hearing to discuss strategies to end agreements between brand-name, generic drugmakers, limit number of plans 0 None
2009-03-31 World Heart Federation, Daiichi Sankyo and Lilly Partner to improve cardiovascular health 0 None
2009-03-31 Basilea Pharmaceutica expands potential commercial availability of Toctino in Europe 0 None
2009-03-30 Mylan's Matrix receives tentative FDA approval under PEPFAR for generic Truvada 0 None
2009-03-30 Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis 0 None
2009-03-30 Court of Appeal for Saskatchewan allows Merck's appeal 0 None
2009-03-30 Wal-Mart in talks with several companies to expand prescription drug discount program for employees 0 None
2009-03-30 FDA approves Afinitor oral tablets (everolimus) for advanced form of kidney cancer 0 None
2009-03-30 FDA approves IXIARO for Japanese encephalitis 0 None
2009-03-30 Senate measure would allow generic versions of biotechnology drugs after five years 0 None
2009-03-29 Takeda expands into Canada 0 None
2009-03-29 Salk Institute forms strategic alliance agreement with sanofi-aventis 0 None
2009-03-29 Mylan confirms four first-to-file challenges 0 None
2009-03-26 Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection 0 None
2009-03-25 New York State to offer low-income, disabled residents prescription drug discount cards 0 None
2009-03-24 Perrigo receives FDA approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion) 0 None
2009-03-24 FDA approves new indication for Wyeth's Tygacil (tigecycline) 0 2
2009-03-24 FABLYN approved in Europe as osteoporosis treatment 0 None
2009-03-24 Drop in Walgreen profits reflects change in consumer prescription needs 0 None
2009-03-24 Clotrimazole drug used to treat skin conditions is a marine pollutant 0 None
2009-03-23 New MEDQUARG guidelines will help detect and study counterfeit medicines 0 None
2009-03-23 Merck Serono launches strategic venture capital fund 0 None
2009-03-23 Merck updates on Schering-Plough merger 0 None
2009-03-23 Federal Court rules FDA must reconsider Plan B decision 0 None
2009-03-23 FDA approves Symbyax for treatment-resistant depression 0 None
2009-03-23 New tuberculosis vaccine effective in animal testing 0 None
2009-03-23 New JAMA policy says whistle-blowers should stay silent while conflict-of-interest investigations are ongoing 0 None
2009-03-23 Some 'pharma' advocates want FDA split into two agencies 0 None
2009-03-22 Carbohydrate-based medicine 0 None
2009-03-22 Nationwide alert on tainted weight loss products 0 None
2009-03-20 Tobacco for drug synthesis 0 None
2009-03-20 Powerful antioxidant found in a tiny plant reduce computer eye strain 0 None
2009-03-20 FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone) 0 None
2009-03-19 Millions could benefit from statins to prevent heart attacks, strokes 0 None
2009-03-19 Experimental vaccine shows promise in preventing cytomegalovirus infection 0 None
2009-03-19 Happy pills in America -- Our complex love affair with designer consciousness 0 3
2009-03-17 FDA accepts IND for Arno Therapeutics' Pan-DAC / Akt inhibitor, AR-42 0 None
2009-03-17 Engineering flu vaccines 0 None
2009-03-16 Sirion Therapeutics sNDA for Durezol to treat uveitis accepted for FDA review 0 None
2009-03-16 Shire withdraws European application for Daytrana (Methylphenidate Transdermal System) 0 None
2009-03-16 New botulinum toxin type A (Reloxin) appears to be well tolerated and may help reduce forehead wrinkles 0 None
2009-03-16 New aspirin recommendation can help prevent heart attacks and strokes among many adults 1 None
2009-03-16 MannKind Corporation submits NDA for Afresa for treatment of diabetes 0 None
2009-03-16 ATCC develops and isolates novel avian flu monoclonal antibodies 0 None
2009-03-15 ADMEcell enters into manufacturing and distribution agreement with Advancell 0 None
2009-03-15 FDA approves first DNA test for two types of HPV 1 None
2009-03-12 Vertex Pharmaceuticals completes acquisition of ViroChem Pharma 0 None
2009-03-12 New drug derived from magnolia trees proves safe, tolerable in preventing blood clots 0 None
2009-03-12 Discovery may lead to immunosuppressant drugs that have fewer adverse side effects 0 None
2009-03-12 Oncolytics Biotech (TSX:ONC, NASDAQ:ONCY) starts U.S. enrolment in trial for non-small cell lung cancer patients 0 None
2009-03-12 DSM obtains exclusive world-wide license for innovative drug delivery technology 0 None
2009-03-12 Roche (SWX: ROG.VX; RO.S) and Genentech (NYSE:DNA) agree to combine 0 None
2009-03-11 Novel anti-inflammatory therapy protects lungs from runaway inflammation 0 5
2009-03-11 Tissue-cultured smallpox vaccine shows promise 0 None
2009-03-11 Eli Lilly granted temporary restraining order to halt launch of generic Raloxifene 0 None
2009-03-11 Immune-based therapy approved in Europe for pediatric cancer patients 0 None
2009-03-11 A vaccine for multiple sclerosis 0 None
2009-03-10 CytoDyn responds to FDA as high court rules agency cannot guarantee drug safety 0 None
2009-03-10 Azaya Therapeutics selected for Nanotechnology Characterization Lab by National Cancer Institute 0 None
2009-03-05 Ranbaxy secures FDA approval for quinapril hydrochloride + hydrochlorothiazide tablets 0 None
2009-03-05 European Commission and US FDA approve intravenous formulation of temozolomide 0 None
2009-03-05 Pharmacies offering no-cost antibiotics should promote responsible use, CDC says 0 None
2009-03-05 Dorgan, McCain, Snowe introduce bill to allow prescription drug reimportation 0 None
2009-03-05 Supreme Court rules against Wyeth in pre-emption case 0 None
2009-03-05 FDA warning on risk of wearing medicated patches during MRIs 0 None
2009-03-04 Off-label drug uses wasting millions, raising health risks 0 None
2009-03-04 FDA accepts IND application for Tigris Pharmaceutical's GGTI-2418 0 None
2009-03-04 Generic biologics face 'tough, long road to realization' 0 None
2009-03-03 FDA warning letter to Genzyme related to Allston manufacturing facility 0 None
2009-03-03 FDA provides positive review of InNexus' lead preclinical drug candidate 0 None
2009-03-03 FDA clears Cellectar's IND application for lead drug candidate 0 None
2009-03-02 Endo Pharmaceuticals licenses investigational drug axomadol from Grunenthal 1 None
2009-03-02 FDA takes action against KV Pharmaceutical Company 0 None
2009-03-02 Wyeth's Prevenar vaccine for pneumococcal disease registered in Russia 0 None
2009-03-01 FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs 0 None

Total

75 posts
3 comments
3 raters